| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $138K | -1.0% |
| SG&A Expense | $1.4M | -28.5% |
| Operating Income | -$1.5M | +26.6% |
| Pre-tax Income | -$1.5M | +26.6% |
| Net Income | -$1.5M | +26.6% |
| EPS (Basic) | -$0.13 | +27.8% |
| EPS (Diluted) | -$0.13 | +27.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $50K | -61.2% |
| Total Assets | $51K | -62.0% |
| Current Liabilities | $3.4M | +49.8% |
| Total Liabilities | $3.4M | +49.8% |
| Stockholders' Equity | -$3.3M | -56.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$664K | +58.9% |
| Financing Cash Flow | $648K | -28.3% |